Evaluation of pancreatic cancer cell lines as a source of cancer stem cells (CSC) and their utilisation for assessing anti-CSC activities of KRAS binders
Background: High incidence of recurrence has been recorded at 80% of pancreatic ductal adenocarcinoma (PDAC) cases, despite tumour resection and an adjuvant chemotherapy with gemcitabine are prescribed. Pancreatic cancer stem cells (CSCs) are believed to have initiated recurrent PDAC. Growing ev...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | الإنجليزية |
| منشور في: |
2020
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://psasir.upm.edu.my/id/eprint/116093/1/116093.pdf |